Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway

Int Immunopharmacol. 2015 Dec;29(2):370-376. doi: 10.1016/j.intimp.2015.10.027. Epub 2015 Oct 24.

Abstract

The purpose of this study was to investigate the protective effect of PD against lipopolysaccharide (LPS)-induced acute lung injury (ALI) and explore its potential mechanism. In vivo, PD and dexamethasone were intraperitoneally administered 1h before LPS stimulation. Then, mice were sacrificed at 6h post-LPS stimulation. Neutrophil number, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in bronchoalveolar lavage fluid (BALF) were determined, as well as lung wet to dry ratio (W/D) and polymorphonuclear (MPO) activity. The protein expressions of Toll like receptor 4 (TLR4), myeloid differentiating factor 88 (MyD88), IL-1R-associated kinases 1 (IRAK1), IRAK4, inhibitor of nuclear factor kappa-B kinase (IKK)α, p-IKKα, IKKβ, p-IKKβ, inhibitor of NF-κB (IκBα), p-IκBα and NF-κB in lung tissues were assessed. Besides, we detected the IL-6, IL-1β, IL-8, TNF-α levels and TLR4, MyD88, NF-κB protein expressions in LPS-induced BEAS-2B cells. Consequently, PD significantly inhibited the levels of W/D, MPO, neutrophils number, TNF-α, IL-6, IL-1β and reversed TLR4-MyD88-NF-κB signaling pathway in lung tissues. In vitro assays, PD effectively negatively mediated the inflammatory cytokines and ameliorated the high expressions of TLR4, MyD88, NF-κB caused by LPS simulation in Human bronchial epithelial BEAS-2B cells. This study indicated that PD played a protective role in LPS-induced ALI and BEAS-2B cells. The results supported further study of PD as potential candidate for acute lung injury.

Keywords: ALI; BEAS-2B cells; Cytokines; LPS; Polydatin; TLR4-MyD88-NF-κB pathway.

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / prevention & control*
  • Animals
  • Bronchoalveolar Lavage Fluid / cytology
  • Cell Line
  • Cytokines / biosynthesis
  • Glucosides / therapeutic use*
  • Leukocyte Count
  • Lipopolysaccharides*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Myeloid Differentiation Factor 88 / drug effects*
  • NF-kappa B / drug effects*
  • Signal Transduction / drug effects
  • Stilbenes / therapeutic use*
  • Toll-Like Receptor 4 / drug effects*

Substances

  • Cytokines
  • Glucosides
  • Lipopolysaccharides
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Stilbenes
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • polydatin